Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid.

Invest Ophthalmol Vis Sci 2016 Oct;57(13):5457-5469

Academic Unit of Ophthalmology, Centre for Translational Inflammation Research, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom 2Birmingham and Midland Eye Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom.

Purpose: Ocular mucous membrane pemphigoid (OcMMP) is a rare autoimmune disorder resulting in progressive conjunctival fibrosis and ocular surface failure leading to sight loss in up to 50%. This study was designed to optimize an ocular surface sampling technique for identification of novel biomarkers associated with disease activity and/or progressive fibrosis.

Methods: Fifty-seven patients with OcMMP underwent detailed examination of conjunctival inflammation and fibrosis using fornix depth measurement. Ocular surface impression cytology (OSIC) to sample superior bulbar conjunctiva combined with flow cytometry (OSIC-flow) profiled infiltrating leukocytes. Profiles were compared with healthy controls (HC) and disease controls (primary Sjögren's syndrome, pSS). Thirty-five OcMMP patients were followed every 3 months for 12 months.

Results: Overall neutrophils were elevated in OcMMP eyes when compared to pSS or HC (109 [18%] neutrophils/impression [NPI]; 2 [0.2%]; 6 [0.8%], respectively [P < 0.0001]) and in OcMMP patients with no visible inflammation when compared with HC (44.3 [7.9%]; 5.8 [0.8%]; P < 0.05). At 12 months follow-up, 53% of OcMMP eyes progressed, and this was associated with baseline conjunctival neutrophilia (P = 0.004). As a potential biomarker, a value of 44 NPI had sensitivity, specificity, and positive predictive values of 75%, 70%, and 73%, respectively. Notably, eyes with no visible inflammation and raised conjunctival neutrophils were more likely to progress and have a greater degree of conjunctival shrinkage compared to those without raised neutrophils.

Conclusions: These data suggest that OSIC-flow cytometric analyses may facilitate repeated patient sampling. Neutrophils may act as a biomarker for monitoring disease activity, progressive fibrosis, and response to therapy in OcMMP even when the eye appears clinically uninflamed.

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.16-19247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072540PMC
October 2016

Publication Analysis

Top Keywords

ocular surface
12
ocmmp patients
8
membrane pemphigoid
8
disease activity
8
mucous membrane
8
ocular mucous
8
visible inflammation
8
conjunctival neutrophils
8
ocmmp eyes
8
ocmmp
7
conjunctival
6
ocular
5
[02%] [08%]
4
[npi] [02%]
4
neutrophils/impression [npi]
4
compared pss
4
eyes compared
4
pss 109
4
109 [18%]
4
[18%] neutrophils/impression
4

Similar Publications

Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid.

Ophthalmology 2003 Mar;110(3):474-80

Department of Neurologic and Visual Sciences, University of Genoa, via Saccari 14, 18038 Sanremo, Genoa, Italy.

Purpose: To evaluate the role and the effectiveness over time of amniotic membrane transplantation (AMT) as a first-step procedure to treat conjunctival reconstruction in late-stage ocular-cicatricial pemphigoid (OCP).

Design: Prospective interventional noncomparative case series.

Participants: Nine eyes (9 patients) with advanced OCP. Read More

View Article and Full-Text PDF
March 2003

Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid.

Am J Pathol 2011 Jan 23;178(1):187-97. Epub 2010 Dec 23.

Department of Ocular Biology and Therapeutics, University College London Institute of Ophthalmology, London, UK.

Ocular mucous membrane pemphigoid is an immunobullous disease in which excessive conjunctival fibrosis causes blindness, and the pathogenesis of scarring is incompletely understood. To establish whether profibrotic fibroblasts with an altered phenotype exist in ocular mucous membrane pemphigoid, we compared the functional characteristics of pemphigoid conjunctival fibroblasts to normal conjunctival fibroblasts with respect to cell division; migration; collagen contraction; matrix metalloproteinase, secretion of collagen and chemokines; and myofibroblast differentiation. We found that pemphigoid fibroblasts showed increased cell division (P = 0. Read More

View Article and Full-Text PDF
January 2011

Conjunctival interleukin-13 expression in mucous membrane pemphigoid and functional effects of interleukin-13 on conjunctival fibroblasts in vitro.

Am J Pathol 2009 Dec 12;175(6):2406-15. Epub 2009 Nov 12.

Department of Ocular Biology and Therapeutics, University College London Institute of Ophthalmology, London, United Kingdom.

Interleukin-13 (IL-13) is the dominant effector cytokine of fibrosis in pulmonary and liver disease. Excessive conjunctival fibrosis in the immunobullous disease ocular mucous membrane pemphigoid (MMP) causes blindness; the pathogenesis of scarring in this disease is incompletely understood. To determine whether IL-13 is involved in conjunctival fibrosis in MMP, we studied the expression of IL-13 in ocular MMP patients before and after systemic immunosuppression and examined the effects of IL-13 on normal human conjunctival fibroblasts. Read More

View Article and Full-Text PDF
December 2009

Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid.

Ocul Immunol Inflamm 2011 Dec;19(6):431-8

Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.

Purpose: To assess the long-term efficacy and tolerability of mycophenolate mofetil (MMF) in the therapy of ocular mucous membrane pemphigoid (OcMMP).

Methods: Ten patients (19 eyes) with OcMMP treated with MMF, who had a follow-up of at least 4 years, were retrospectively analyzed. Main outcome measures were inflammatory control, progression of cicatrization, and side effects. Read More

View Article and Full-Text PDF
December 2011